C1q acts in the tumour microenvironment as a cancer-promoting factor independently of complement activation. Nat Commun 2016;7:10346.
. In vivo distribution of β2 glycoprotein I under various pathophysiologic conditions. Blood 2011;118(15):4231-8.
. A non-complement-fixing antibody to β2 glycoprotein I as a novel therapy for antiphospholipid syndrome. Blood 2014;123(22):3478-87.
.